Lakewood Amedex Inc
Lakewood Amedex is developing a revolutionary portfolio of products to meet the infectious disease challenges of the 21st century.
- Stage Concept Only
- Industry Not Set
- Location Lakewood Ranch, FL, USA
- Currency USD
- Website lakewoodamedex.com
Company Summary
Lakewood-Amedex, a private development stage biopharmaceutical company, is developing a diverse portfolio of broad spectrum anti-bacterials, anti-virals, and targeted therapeutics. NuBiotics are a synthetic broad spectrum first in class group of anti-bacterial compounds that represent a first line defence against the increasing number of antibiotic resistant bacteria.
Team
-
Steve ParkinsonPresident and CEO
Mr. Parkinson has over 28 years experience in the biotechnology and biopharmaceutical industry. As co-founder and CEO of TranXenoGen, Mr. Parkinson oversaw its IPO and admission to AIM in July of 2000, increasing its market value from $90M to $240M within one year. As President and CEO of CereMedix, a drug discovery and development company, he advanced their first product to clinical trials.
-
Paul DiTullioVP Product Development
Mr. DiTullio has 20 years in the biotechnology/biopharmaceutical industry that has provided a broad range of scientific, finance, and business experience associated with early stage company development. Previously, Mr. DiTullio was a co-founder and VP of Product Development for TranXenoGen Inc and was responsible for coordinating all research and product development activities.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.